HCA

SEC source: 0001209191-18-013633 · doc4.xml · derivative · entry 7

JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,547 shares

Expires 2025-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: On February 25, 2015, the reporting person was granted 9,093 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date.

SEC source: 0001209191-18-013633 · doc4.xml · nonDerivative · entry 4

JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,033,642

SEC source: 0001209191-18-013633 · doc4.xml · nonDerivative · entry 3

JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,038,091

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001209191-18-013654 · doc4.xml · derivative · entry 5

YUSPEH ALAN R · CIK 0001216859 · SVP & Chief Ethics Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,625

Underlying: Common Stock · 2,625 shares

Expires 2024-02-05

F3 · balance_after: On February 5, 2014, the reporting person was granted 17,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 2,625 stock appreciation rights.

SEC source: 0001209191-18-013654 · doc4.xml · nonDerivative · entry 2

YUSPEH ALAN R · CIK 0001216859 · SVP & Chief Ethics Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,184

SEC source: 0001209191-18-013654 · doc4.xml · nonDerivative · entry 1

YUSPEH ALAN R · CIK 0001216859 · SVP & Chief Ethics Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,334

F1 · kind: On February 4, 2015, the reporting person was granted 4,400 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013653 · doc4.xml · derivative · entry 4

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 825

Underlying: Common Stock · 825 shares

Expires 2024-02-05

F3 · balance_after: On February 5, 2014, the reporting person was granted 5,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 825 stock appreciation rights.

SEC source: 0001209191-18-013653 · doc4.xml · nonDerivative · entry 3

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,409

SEC source: 0001209191-18-013653 · doc4.xml · nonDerivative · entry 2

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,045

F2 · kind: On February 5, 2014, the reporting person was granted 1,500 restricted stock units. The restricted stock units were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the restricted stock units subject to such criteria vested, resulting in the vesting of 225 restricted stock units.

SEC source: 0001209191-18-013653 · doc4.xml · nonDerivative · entry 1

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,820

F1 · kind: On February 4, 2015, the reporting person was granted 3,200 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013652 · doc4.xml · derivative · entry 5

WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,250

Underlying: Common Stock · 5,250 shares

Expires 2024-02-05

F3 · balance_after: On February 5, 2014, the reporting person was granted 35,000 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 5,250 stock appreciation rights.

SEC source: 0001209191-18-013652 · doc4.xml · nonDerivative · entry 2

WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 252,293

SEC source: 0001209191-18-013652 · doc4.xml · nonDerivative · entry 1

WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 257,752

F1 · kind: On February 4, 2015, the reporting person was granted 8,800 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013651 · doc4.xml · derivative · entry 4

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 750

Underlying: Common Stock · 750 shares

Expires 2024-02-05

F3 · balance_after: On February 5, 2014, the reporting person was granted 5,000 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 750 stock appreciation rights.

SEC source: 0001209191-18-013651 · doc4.xml · nonDerivative · entry 3

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,057

SEC source: 0001209191-18-013651 · doc4.xml · nonDerivative · entry 2

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,706

F2 · kind: On February 5, 2014, the reporting person was granted 1,750 restricted stock units. The restricted stock units were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the restricted stock units subject to such criteria vested, resulting in the vesting of 263 restricted stock units.

SEC source: 0001209191-18-013651 · doc4.xml · nonDerivative · entry 1

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,443

F1 · kind: On February 4, 2015, the reporting person was granted 2,200 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013648 · doc4.xml · derivative · entry 6

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,125

Underlying: Common Stock · 4,125 shares

Expires 2024-02-05

F3 · balance_after: On February 5, 2014, the reporting person was granted 27,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 4,125 stock appreciation rights.

SEC source: 0001209191-18-013648 · doc4.xml · nonDerivative · entry 2

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,362

SEC source: 0001209191-18-013648 · doc4.xml · nonDerivative · entry 1

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,186

F1 · kind: On February 4, 2015, the reporting person was granted 7,400 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013650 · doc4.xml · derivative · entry 9

STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,125

Underlying: Common Stock · 4,125 shares

Expires 2024-02-05

F3 · balance_after: On February 5, 2014, the reporting person was granted 27,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 4,125 stock appreciation rights.

SEC source: 0001209191-18-013650 · doc4.xml · nonDerivative · entry 2

STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,310

SEC source: 0001209191-18-013650 · doc4.xml · nonDerivative · entry 1

STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,236

F1 · kind: On February 4, 2015, the reporting person was granted 8,800 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013649 · doc4.xml · derivative · entry 7

STEAKLEY JOSEPH N · CIK 0001216853 · SVP-Internal Audit Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,625

Underlying: Common Stock · 2,625 shares

Expires 2024-02-05

F4 · balance_after: On February 5, 2014, the reporting person was granted 17,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 2,625 stock appreciation rights.

SEC source: 0001209191-18-013649 · doc4.xml · nonDerivative · entry 2

STEAKLEY JOSEPH N · CIK 0001216853 · SVP-Internal Audit Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,032.4249

F2 · balance_after: Includes 1,424.4249 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-18-013649 · doc4.xml · nonDerivative · entry 1

STEAKLEY JOSEPH N · CIK 0001216853 · SVP-Internal Audit Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,216.4249

F1 · kind: On February 4, 2015, the reporting person was granted 4,400 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

F2 · balance_after: Includes 1,424.4249 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-18-013647 · doc4.xml · derivative · entry 4

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 675

Underlying: Common Stock · 675 shares

Expires 2024-02-05

F3 · balance_after: On February 5, 2014, the reporting person was granted 4,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 675 stock appreciation rights.

SEC source: 0001209191-18-013647 · doc4.xml · nonDerivative · entry 3

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,432

SEC source: 0001209191-18-013647 · doc4.xml · nonDerivative · entry 2

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,288

F2 · kind: On February 5, 2014, the reporting person was granted 1,500 restricted stock units. The restricted stock units were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the restricted stock units subject to such criteria vested, resulting in the vesting of 225 restricted stock units.

SEC source: 0001209191-18-013647 · doc4.xml · nonDerivative · entry 1

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,063

F1 · kind: On February 4, 2015, the reporting person was granted 2,400 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013646 · doc4.xml · derivative · entry 7

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,125

Underlying: Common Stock · 4,125 shares

Expires 2024-02-05

F3 · balance_after: On February 5, 2014, the reporting person was granted 27,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 4,125 stock appreciation rights.

SEC source: 0001209191-18-013646 · doc4.xml · nonDerivative · entry 4

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,976

SEC source: 0001209191-18-013646 · doc4.xml · nonDerivative · entry 3

Paslick P. Martin · CIK 0001551011 · SVP and CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,800

F1 · kind: On February 4, 2015, the reporting person was granted 7,400 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013645 · doc4.xml · derivative · entry 6

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 975

Underlying: Common Stock · 975 shares

Expires 2024-02-05

F3 · balance_after: On February 5, 2014, the reporting person was granted 6,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 975 stock appreciation rights.

SEC source: 0001209191-18-013645 · doc4.xml · nonDerivative · entry 5

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,196.5358

SEC source: 0001209191-18-013645 · doc4.xml · nonDerivative · entry 4

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,834.5358

F2 · kind: On February 5, 2014, the reporting person was granted 1,500 restricted stock units. The restricted stock units were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the restricted stock units subject to such criteria vested, resulting in the vesting of 225 restricted stock units.

SEC source: 0001209191-18-013645 · doc4.xml · nonDerivative · entry 3

Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,609.5358

F1 · kind: On February 4, 2015, the reporting person was granted 3,200 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013644 · doc4.xml · derivative · entry 6

Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,050

Underlying: Common Stock · 1,050 shares

Expires 2024-02-05

F4 · balance_after: On February 5, 2014, the reporting person was granted 7,000 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 1,050 stock appreciation rights.

SEC source: 0001209191-18-013644 · doc4.xml · nonDerivative · entry 3

Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,994.8654

SEC source: 0001209191-18-013644 · doc4.xml · nonDerivative · entry 2

Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,662.8654

F2 · kind: On February 5, 2014, the reporting person was granted 2,000 restricted stock units. The restricted stock units were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the restricted stock units subject to such criteria vested, resulting in the vesting of 300 restricted stock units.

SEC source: 0001209191-18-013644 · doc4.xml · nonDerivative · entry 1

Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,362.8654

F1 · kind: On February 4, 2015, the reporting person was granted 4,400 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013643 · doc4.xml · derivative · entry 6

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 825

Underlying: Common Stock · 825 shares

Expires 2024-02-05

F4 · balance_after: On February 5, 2014, the reporting person was granted 5,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 825 stock appreciation rights.

SEC source: 0001209191-18-013643 · doc4.xml · nonDerivative · entry 3

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,314

SEC source: 0001209191-18-013643 · doc4.xml · nonDerivative · entry 2

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,592

F2 · kind: On February 5, 2014, the reporting person was granted 1,500 restricted stock units. The restricted stock units were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the restricted stock units subject to such criteria vested, resulting in the vesting of 225 restricted stock units.

SEC source: 0001209191-18-013643 · doc4.xml · nonDerivative · entry 1

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,367

F1 · kind: On February 4, 2015, the reporting person was granted 4,400 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013642 · doc4.xml · derivative · entry 6

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,050

Underlying: Common Stock · 1,050 shares

Expires 2024-02-05

F4 · balance_after: On February 5, 2014, the reporting person was granted 7,000 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 1,050 stock appreciation rights.

SEC source: 0001209191-18-013642 · doc4.xml · nonDerivative · entry 3

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,300

SEC source: 0001209191-18-013642 · doc4.xml · nonDerivative · entry 2

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,451

F2 · kind: On February 5, 2014, the reporting person was granted 2,000 restricted stock units. The restricted stock units were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the restricted stock units subject to such criteria vested, resulting in the vesting of 300 restricted stock units.

SEC source: 0001209191-18-013642 · doc4.xml · nonDerivative · entry 1

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,151

F1 · kind: On February 4, 2015, the reporting person was granted 4,400 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.

SEC source: 0001209191-18-013641 · doc4.xml · derivative · entry 10

CAMPBELL VICTOR L · CIK 0001216831 · SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,375

Underlying: Common Stock · 3,375 shares

Expires 2024-02-05

F3 · balance_after: On February 5, 2014, the reporting person was granted 22,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 3,375 stock appreciation rights.